BDTX Earnings

Quarterly EPS
$-0.28
Q3 2024
$-0.28
Q4 2024
$1.00
Q1 2025
$-0.19
Q2 2025
$-0.15
Q3 2025
$-0.26
Q4 2025
$-0.16
Q1 2026
$-0.17
Q2 2026
Latest RevenueN/A
Latest Net Income-9905000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.170-9905000+10.5%
Q1 2026-$0.160-9036000-100.0%-116.0%
Q4 2025-$0.260-15116000+7.1%
Q3 2025-$0.150-8498000+46.4%
Q2 2025-$0.190-10561000+47.2%
Q1 2025$1.0070.0M56.5M+385.7%
Q4 2024-$0.280-15985000+24.3%
Q3 2024-$0.280-15557000+37.8%
Q2 2024-$0.360-19909000
Q1 2024-$0.350-18225000
Q4 2023-$0.370-19408000
Q3 2023-$0.450-23007000
Black Diamond Therapeutics (BDTX) — Earnings